Artwork

Content provided by ISN, Roberto Pecoits-Filho, and Smeeta Sinha. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ISN, Roberto Pecoits-Filho, and Smeeta Sinha or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Season 3 Episode 2: Diagnosis and Management of Complement Mediated Kidney Diseases Supported by Novartis

40:47
 
Share
 

Manage episode 366787198 series 3486279
Content provided by ISN, Roberto Pecoits-Filho, and Smeeta Sinha. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ISN, Roberto Pecoits-Filho, and Smeeta Sinha or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Drs Namrata Parikh, Gary Chan and Nick Medjeral-Thomas are nephrologists and complement enthusiasts interested in the diagnosis and management of complement mediated kidney diseases. In this conversation, we discussed key clinical and pathology features of inappropriate, pathogenic complement activity that guide physicians to a diagnosis of C3 glomerulopathy. We discussed differences in investigation and management strategies between our respective clinical centers in Ottawa, Hong Kong and London, including access to clinical trials of therapeutic complement inhibitors. To finish, we speculated on the future impact on clinical nephrology of complement pathway analysis and inhibition.
Make sure to also check out the Complement-Mediated Kidney Diseases Toolkit here

  continue reading

41 episodes

Artwork
iconShare
 
Manage episode 366787198 series 3486279
Content provided by ISN, Roberto Pecoits-Filho, and Smeeta Sinha. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ISN, Roberto Pecoits-Filho, and Smeeta Sinha or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Drs Namrata Parikh, Gary Chan and Nick Medjeral-Thomas are nephrologists and complement enthusiasts interested in the diagnosis and management of complement mediated kidney diseases. In this conversation, we discussed key clinical and pathology features of inappropriate, pathogenic complement activity that guide physicians to a diagnosis of C3 glomerulopathy. We discussed differences in investigation and management strategies between our respective clinical centers in Ottawa, Hong Kong and London, including access to clinical trials of therapeutic complement inhibitors. To finish, we speculated on the future impact on clinical nephrology of complement pathway analysis and inhibition.
Make sure to also check out the Complement-Mediated Kidney Diseases Toolkit here

  continue reading

41 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide